CLOs on the Move

Conor Medsystems

www.conormed.com

 
Conor Medsystems, Inc. develops controlled vascular drug delivery technologies. It has initially focused on the development of drug-eluting stents to treat coronary artery disease. Its stents have been specifically designed for vascular drug delivery, in
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Accure Acne

At Accure, we are wholly committed to developing revolutionary solutions to provide a long-lasting, durable response to acne. We know that acne can have a devastating social, psychological, physical, and economic impact on patients around the world. We are pioneering transformative solutions that will answer this unmet need and have a positive and profound impact on patients and providers worldwide.

Home Care Specialists

Home Care Specialists is a Haverhill, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biosensors International-Usa

Biosensors International-Usa is a Newport Beach, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Stereo Optical Co.

Stereo Optical Co. is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Corindus

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company`s CorPath® System is the first FDA-cleared medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."